OmniAb OABI
NASDAQ OABI
$4.69 +0.10 (+2.18%)
At close: Oct 19, 2026 · 4:00 PM EDT

OmniAb (OABI) Gains from Investment Securities (2022)

Updated

Analysis

OmniAb (OABI) Gains from Investment Securities (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn
10 OmniAb 603.40 Mn 388.81 Mn 12.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -1.44 Mn
Sep 30, 2022 1.09 Mn
Jun 30, 2022 297,047.00
Mar 31, 2022 51,285.00
API Access

OmniAb Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=OABI&period=max&api_key=YOUR_API_KEY